Vertex Pharmaceuticals
Generated by Meeveem AI
"A global biotechnology company creating transformative medicines for serious diseases"
About Vertex Pharmaceuticals
Vertex Pharmaceuticals discovers, develops and produces medicines for serious diseases. Its approved therapies cover cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassaemia, acute pain and acromegaly. Its research includes cell and genetic therapies and investigational treatments for type 1 diabetes, kidney diseases and neuropathic pain.
Founded in 1989, Vertex has its global headquarters in Boston, Massachusetts, and international headquarters in London, alongside a UK research site in Oxfordshire. The company reported approximately 6,400 employees worldwide at the end of 2025. Research and development accounted for more than half of its business operating expenses in 2025.
Development across teams
Vertex describes career development opportunities that include job rotations, mentoring and training. Its five global employee resource networks are open to all employees and connect colleagues across levels and functions, alongside learning resources and forums.
6400
Team Members
1989
Founded
Pharma
Sector
Hybrid
Work Environment